Cardiol Therapeutics Inc. (TSX:CRDL)
Canada
· Delayed Price · Currency is CAD 1.330
+0.030 (2.31%)
Mar 9, 2026, 4:00 PM EST
Cardiol Therapeutics Employees
Cardiol Therapeutics had 18 employees as of December 31, 2024. The number of employees increased by 12 or 200.00% compared to the previous year.
Employees
18
Change
12
Growth
200.00%
Revenue / Employee
n/a
Profits / Employee
-1.93M CAD
Market Cap
144.22M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18 | 12 | 200.00% |
| Dec 31, 2018 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ascend Wellness Holdings | 2,400 |
| HLS Therapeutics | 92 |
| Charlotte's Web Holdings | 112 |
| Auxly Cannabis Group | 388 |
| Medexus Pharmaceuticals | 91 |
| Planet 13 Holdings | 783 |
| Aurora Cannabis | 1,073 |
| Organigram Global | 1,137 |
Cardiol Therapeutics News
- 4 days ago - Cardiol Therapeutics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
- 12 days ago - Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference - Newsfile Corp
- 27 days ago - Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure - Newsfile Corp
- 6 weeks ago - Cardiol Therapeutics Announces Closing of Bought Deal Financing and Full Exercise of Over-Allotment Option for Gross Proceeds of $14.85 Million - Newsfile Corp
- 7 weeks ago - Cardiol Therapeutics announces $13.5M bought-deal private placement - Seeking Alpha
- 7 weeks ago - Cardiol Therapeutics Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Newsfile Corp
- 7 weeks ago - Cardiol Therapeutics Inc. Announces Bought Deal Financing for Gross Proceeds of $13.5 Million - Newsfile Corp
- 7 weeks ago - Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis - Newsfile Corp